Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan
- 1 November 2000
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 356 (9241) , 1565-1569
- https://doi.org/10.1016/s0140-6736(00)03128-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in IranPublished by Elsevier ,1999
- Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, IranThe Lancet, 1998
- Treatment of visceral leishmaniasis with sodium stibogluconate in Sudan: management of those who do not respondPathogens and Global Health, 1998
- Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG. I: Skin-test reactivity, T-cell proliferation and interferon-γ productionVaccine, 1994
- Induction and modulation of the immune response to Leishmania by Montenegro's skin testTransactions of the Royal Society of Tropical Medicine and Hygiene, 1993
- Kala-azar in displaced people from southern Sudan: epidemiological, clinical and therapeutic findingsTransactions of the Royal Society of Tropical Medicine and Hygiene, 1991
- Outbreak of kala-azar in the SudanThe Lancet, 1990
- EPIDEMIC VISCERAL LEISHMANIASIS IN SOUTHERN SUDANThe Lancet, 1989
- A simple and economical direct agglutination test for serodiagnosis and sero-epidemiological studies of visceral leishmaniasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1986
- Measurement of Delayed Skin-Test ResponsesNew England Journal of Medicine, 1975